SNC Therapeutics Inc. employs a disruptive drug and nonviral gene delivery platform technology for rational immunotherapy.  Our synthetic nanocarriers (SNCs) permit scalable, versatile, and controlled drug delivery to and/or transfection of diverse cell populations while minimizing toxicity and side effects.